She
defervesced, her abdominal pain improved, and the recommendation was made to convert her shunt system to a ventriculoatrial (VA) shunt 2-3 weeks after sterilization of the central nervous system.
The patient
defervesced after four days of intravenous piperacillin-tazobactam.
At the time of discharge on hospital day 5, the patient had
defervesced and her inflammatory markers had decreased, with a C-reactive protein of 2.61 at the time of discharge.
She immediately
defervesced after empirical Piperacilin plus Tazobactam and Gentamicin therapy (providing broad spectrum coverage against Gram positive and Gram negative bacteria, including Pseudomonas aeruginosa) was initiated, but on day 19 post induction the fever relapsed, without any other further clinical evidence of infection.